# Technical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study.

- **DOI:** [10.32074/1591-951x-1936](https://doi.org/10.32074/1591-951x-1936)
- **Rating:** Limited (2.7 out of 5)
- **Verdict:** A useful MinION feasibility pilot whose ten-sample comparison and unresolved low-VAF workflow cannot establish comparable diagnostic accuracy.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.32074%2F1591-951x-1936

## Key claims

1. The adapted ONT workflow demonstrated high concordance rate in detecting clinically relevant molecular alterations on short-read fragments, achieving comparable accuracy with standardized second generation NGS platforms on tissue and liquid biopsy samples.
   - Support: Tentative
   - Type: Primary finding
   - Basis: ten specimens, one liquid biopsy, and no bidirectional accuracy estimates cannot establish comparable diagnostic accuracy
   - Location: Abstract, Results
2. A perfect match between MinION workflow and conventional short-read sequencing pipeline was identified. In detail, 14 single-nucleotide variants (SNVs) across all 10 samples, were confirmed by ONT sequencing.
   - Support: Tentative
   - Type: Secondary
   - Basis: one-directional recovery lacks ONT-only call, indel, precision, and independently verified low-VAF accounting
   - Location: Results, paragraph 2
3. SNVs showing a variant allele frequency (VAF) ranging from 0.5% to 5.0% were consistently identified by the GATK MuTect2 pipeline and confirmed visually inspecting BAM files on Genomics Viewer (IGV) tool.
   - Support: Tentative
   - Type: Secondary
   - Basis: visual confirmation uses the same ONT reads and conflicts with the stated ≥5% filtering threshold
   - Location: Results, paragraph 3

## Strengths

- **Routine clinical specimens tested directly** The series includes nine archived FFPE NSCLC specimens and one GIST liquid-biopsy specimen, providing an intended-use feasibility setting rather than synthetic material alone.
  - Dimension: methodological rigour
  - Location: Study Design
- **Specific MinION workflow is documented** The Methods identify the R10.4.1 flow cell, V14 barcoding chemistry, SUP basecalling model, GRCh38 alignment, and GATK calling tools, supporting technical reproducibility at the protocol level.
  - Dimension: contribution
  - Location: MinION Protocol
- **Limitations are explicitly identified** The Discussion recognises that the sample cannot establish robust performance and also identifies the narrow panel, missing clinical outcomes, and cross-platform reference differences.
  - Dimension: positioning
  - Location: Discussion, limitations paragraph

## Limitations

- **Low-VAF workflow remains internally inconsistent** The MinION Protocol states a VAF threshold of at least 5%, while Results report calls from 0.1% to 5.0% after visual inspection. The paper does not clearly identify which pipeline generated these calls or provide an independent confirmation strategy.
  - Dimension: methodological rigour
  - Location: MinION Protocol; Results, paragraph 3
- **Analytical accounting cannot be reconstructed** The Ion protocol describes eight pooled libraries although ten samples are reported, and a run used approximately 200 active pores despite an 800-pore minimum in Methods. These inconsistencies bear on the complete-concordance and feasibility claims.
  - Dimension: methodological rigour
  - Location: SiRe Protocol; MinION Protocol; Discussion, flow-cell comparison
- **Accuracy claims exceed reported evidence** Fourteen recovered SNVs in ten samples are described as a perfect match and comparable accuracy without false-positive accounting, confidence intervals, indel performance, or a reported correlation statistic.
  - Dimension: reporting
  - Location: Abstract, Results, paragraphs 2–3; Discussion

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - SNVs showing a variant allele frequency (VAF) ranging from 0.5% to 5.0% were consistently identified by the GATK MuTect2 pipeline and confirmed visually inspecting BAM files on Genomics Viewer (IGV) tool: "Filtering chain was able to detect molecular alterations with variant allele fraction (VAF) ≥ 5% adopting the GATK HaplotypeCaller (germline alterations) and GATK Mutec2 (somatic variations) pipelines." (MinION Protocol) vs "Notably, SNVs showing a variant allele frequency (VAF) ranging from 0.5% to 5.0% were consistently identified by the GATK MuTect2 pipeline and confirmed visually inspecting BAM files on Genomics Viewer (IGV) tool. Notably, a visual inspection of the raw data using the IGV tool confirmed the detection of low-frequency genomic alterations, ranging from 0.1% to 5.0% MAF, identified by the SiRe™ MinION pipeline." (Results, final paragraph). The reported detection ranges extend below the stated ≥5% filtering threshold, but the text does not identify an alternative filter or provide call-level information from which to recompute the low-frequency detection result. → Effect on result unclear
- **Reporting and transparency:** Noted. Reporting ambiguities concern the panel's six-versus-seven gene count, PromethION-versus-MinION naming, eight pooled libraries versus ten samples, the 800-pore criterion versus a 200-pore run, 24 versus 48 hours of sequencing, and the unit of median DNA concentration; none establishes a corrected accuracy or concordance result.
  - Conflict of interest: declared · Ethics approval: declared · Preregistration: not stated · Data availability: declared · Code availability: not stated
- **Reference integrity:** Noted
  - 29 references in manuscript
  - 28 of 28 checkable references found in an index
  - 1 are books, websites or datasets — counted, but not index-checkable
  - 1 DOI points to a different paper:
    - #25 Jasper RJ, McDonald TK, Singh P, et al. Accuracy of variant calling methods. Mol Ecol Resour. 2022;22(7):2524-2533. https://doi.org/10.1111/1755-0998.13628 (DOI resolves to: “Evaluating the accuracy of variant calling methods using the frequency of parent‐offspring genotype mismatch” — Jasper, 2022 (Molecular Ecology Resources)) https://doi.org/10.1111/1755-0998.13628
  - Citation details diverge for 3 references:
    - #8 Pei XM, Yeung MHY, Wong ANN, et al. Targeted sequencing approach and clinical applications. Cells. 2023;12(3):493. https://doi.org/10.3390/cells12030493 (DOI resolves to: “Targeted Sequencing Approach and Its Clinical Applications for the Molecular Diagnosis of Human Diseases” — Pei, 2023 (Cells). Differs from the DOI’s record on: title, authors) https://doi.org/10.3390/cells12030493
    - #9 Tyler AD, Mataseje L, Urfano CJ, et al. Evaluation of Oxford Nanopore MinION sequencing device. Sci Rep. 2018;8(1):10931. https://doi.org/10.1038/s41598-018-29334-5 (DOI resolves to: “Evaluation of Oxford Nanopore’s MinION Sequencing Device for Microbial Whole Genome Sequencing Applications” — Tyler, 2018 (Scientific Reports). Differs from the DOI’s record on: title, authors) https://doi.org/10.1038/s41598-018-29334-5
    - #18 Mimosa ML, Al-Ameri W, Simpson JT, et al. Detection of IDH mutations using nanopore sequencing. J Mol Diagn. 2023;25(3):133-142. https://doi.org/10.1016/j.jmoldx.2022.12.001 (DOI resolves to: “A Novel Approach to Detect IDH Point Mutations in Gliomas Using Nanopore Sequencing” — Mimosa, 2023 (The Journal of Molecular Diagnostics). Differs from the DOI’s record on: title, authors) https://doi.org/10.1016/j.jmoldx.2022.12.001
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
